Results of clinical trials of ovostat as a contraceptive and therapeutic agent
Shturkalev, I.; Katsulov, A.
Akusherstvo i Ginekologiia 9(5): 383-387
1970
ISSN/ISBN: 0324-0959 PMID: 5526636 Document Number: 507786
Document emailed within 1 workday
Related Documents
Bergmann, J.F.; Lagier, G.; Calvo, F.; Chazelle, F.; Caulin, C. 1988: Independent controls of quality in therapeutic trials. Apropos of an experience of 11 external audits of clinical investigators performed in 2 European multicenter trials Therapie 43(5): 379-384Otani, Y.; Kawagoe, T. 1968: Contraceptive effects of a jelly with a surface active agent as the basic and ingredient clinical experiences with a new contraceptive drug, Penicap Sanfujinka no Jissai. Practice of Gynecology and Obstetrics 17(7): 657-659
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
da Silva, L.C.; Sette, H.; Chamone, D.A.; Sáez-Alquezar, A.; Punskas, J.A.; Raia, S. 1975: Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent Revista do Instituto de Medicina Tropical de Sao Paulo 17(5): 307-311
Baron, J.C.; Bousser, M.G. 1982: Controlled therapeutic trials in migraine: methodology and results Revue Neurologique (Paris) 138(4): 279-295
Darney, P. 1993: Safety and efficacy of a triphasic oral contraceptive containing desogestrel: Results of three multicenter trials Contraception 48(4): 323-337
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Dhall, K.; Dogra, M. 1988: Phase i and Ii clinical trials with Vicoa Indica (Banjauri), a herbal medicine, as an antifertility agent Contraception 37(1): 75-84
Martin, D.S.; Stolfi, R.L.; Sawyer, R.C.; Young, C.W. 1985: Application of biochemical modulation with a therapeutically inactive modulating agent in clinical trials of cancer chemotherapy Cancer Treatment Reports 69(4): 421-423
Kelloff, G.J.; Boone, C.W.; Steele, V.E.; Crowell, J.A.; Lubet, R.; Sigman, C.C. 1994: Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials Cancer Research 54(7 Suppl): 2015s-2024s
Soto, J.; Sacristán, J.A.; Alsar, M.J. 1992: Therapeutic compliance in clinical trials Medicina Clinica 98(7): 276
Soares, I.; Carneiro, A.ón.V. 2002: Basics of methodologic analysis of therapeutic trials. Part III: applicability of the results to the individual patient Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 21(6): 783-795
1989: New male contraceptive entering clinical trials worldwide Contraceptive Technology Update 10(10): 142-143
Hebert, A.A.; Albareda, N.; Rosen, T.; Torrelo, A.; Grimalt, R.; Rosenberg, N.; Zsolt, I.; Masramon, X. 2018: Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Pooled Analysis of Phase 3 Clinical Trials Journal of Drugs in Dermatology: Jdd 17(10): 1051-1057
Podzich, M. 1982: Percutaneous therapy of soft tissue rheumatic diseases. Clinical trials of the non-steroid anti-phlogistic agent Rheumon gel ZFA. Zeitschrift für Allgemeinmedizin 58(16): 921-924
Ramfjord, S.P. 1971: Clinical trials of therapeutic measures in periodontics International Dental Journal 21(1): 16-32
Brierley, J.; Larcher, V. 2014: Clinical trials of contraceptive agents in those under 16 years of age: are they necessary, ethical or legal? Archives of disease in childhood 99(12): 1070-1073
Haspels, A.A. 1983: Clinical experience with a low-dose contraceptive agent. European studies Journal of Reproductive Medicine 28(1 Suppl): 71-76
Matanic, V. 1970: Clinical studies and therapeutic trials with a new phlebotropic substance Zeitschrift für Allgemeinmedizin 46(10): 530-534
Lugosi, L.; Molnár, I. 2000: Meta-analysis of therapeutic and preventive clinical trials Orvosi Hetilap 141(51): 2779-2784